| 12281174 |
High-affinity anti-MERTK antibodies and uses thereof |
Masoud Tavazoie, Isabel Kurth, Shugaku Takeda, Celia Andreu-Agullo |
2025-04-22 |
| 12241097 |
Compositions and methods for adoptive cell therapy for cancer |
David A. Scheinberg, Thomas J. Gardner, Derek Shieh Tan, Jonghan Lee |
2025-03-04 |
| 11891416 |
Recombinant viral vectors |
Christopher L. Parks, Sanjay K. Phogat, Timothy J. Zamb |
2024-02-06 |
| 11795219 |
Antibody molecules for cancer treatment |
Markus ZETTL, Otmar Schaaf, Melanie WURM, Jean-Francois FORTIN, Scott Ronald Brodeur +9 more |
2023-10-24 |
| 11242407 |
High-affinity anti-MERTK antibodies and uses thereof |
Masoud Tavazoie, Isabel Kurth, Shugaku Takeda, Celia Andreu-Agullo |
2022-02-08 |
| 11028169 |
Antibody molecules for cancer treatment |
Markus ZETTL, Otmar Schaaf, Melanie WURM, Jean-Francois FORTIN, Scott Ronald Brodeur +7 more |
2021-06-08 |
| 10844095 |
Recombinant viral vectors |
Christopher L. Parks, Sanjay K. Phogat, Timothy J. Zamb |
2020-11-24 |
| 10202424 |
Recombinant viral vectors |
Christopher L. Parks, Sanjay K. Phogat, Timothy J. Zamb |
2019-02-12 |
| 9944935 |
Methods to improve vector expression and genetic stability |
Christopher L. Parks, Kevin Wright, Maoli Yuan, Christy Jurgens, Xinsheng Zhang +5 more |
2018-04-17 |
| 9802986 |
Recombinant viral vectors |
Christopher L. Parks, Sanjay K. Phogat, Timothy J. Zamb |
2017-10-31 |
| 9402894 |
Viral particles derived from an enveloped virus |
C. Richter King, Michael Caulfield, Christopher L. Parks |
2016-08-02 |
| 9347065 |
Methods to improve vector expression and genetic stability |
Christopher L. Parks, Kevin Wright, Maoli Yuan, Christy Jurgens, Xinsheng Zhang +5 more |
2016-05-24 |